Characteristics of Patients in Study
| SUVmean for… | |||||||
|---|---|---|---|---|---|---|---|
| Patient no. | Age (y) | Sex | Location of lesion | First visit | Second visit | Δ t (d) | Cancer diagnosis |
| 1 | 42 | F | Lung | 10.72 | 10.59 | 1 | NSCLC |
| 2 | 58 | F | Proximal femur | 3.69 | 4.11 | 3 | Breast |
| 3 | 60 | F | Mediastinum | 10.94 | 11.14 | 1 | Breast |
| 4 | 65 | F | Lung | 1.49 | 1.78 | 5 | Breast |
| 5 | 71 | M | Lung | 4.75 | 4.76 | 1 | NSCLC |
| 6 | 48 | F | Clavicle | 5.82 | 6.11 | 2 | Head and neck |
| 7 | 65 | M | Esophagus | 7.11 | 6.66 | 2 | Esophageal |
| 8 | 54 | M | Esophagus | 8.74 | 8.69 | 4 | Esophageal |
| 9 | 25 | M | Lung | 4.54 | 4.74 | 4 | Lymphoma |
| 10 | 49 | M | Neck | 4.16 | 4.34 | 2 | Esophageal |
| 11 | 68 | M | Mediastinum | 2.67 | 2.40 | 1 | Prostate |
| 12 | 69 | M | Mediastinum | 17.48 | 17.35 | 2 | NSCLC |
| 13 | 61 | M | Lung | 11.11 | 10.86 | 1 | NSCLC |
| 14 | 62 | F | Lung | 5.10 | 5.22 | 1 | NSCLC |
| 15 | 66 | F | Mediastinum | 3.90 | 3.67 | 4 | Breast |
| 16 | 64 | F | Pelvis | 4.10 | 4.48 | 5 | Breast |
| 17 | 72 | F | Lung | 2.23 | 2.25 | 5 | Melanoma |
| 18 | 62 | M | Lung | 9.14 | 9.06 | 3 | NSCLC |
| 19 | 70 | M | Liver | 7.95 | 7.96 | 1 | Colorectal |
| 20 | 69 | M | Mediastinum | 4.28 | 4.03 | 1 | Thyroid |
| 21 | 53 | M | Lung | 1.86 | 2.23 | 3 | Head and neck |
| 22 | 69 | M | Lung | 8.07 | 8.36 | 4 | NSCLC |
| 23 | 64 | M | Abdomen | 6.08 | 6.40 | 5 | Renal |
| 24 | 55 | F | Mediastinum | 10.30 | 9.91 | 2 | Breast |
| 25 | 72 | M | Mediastinum | 5.14 | 4.82 | 1 | NSCLC |
| 26 | 53 | M | Mediastinum | 5.27 | 4.93 | 5 | NSCLC |
Δ t = number of days between visits; NSCLC = non–small-cell lung cancer.